Previous Section Index Home Page

13 Jul 2004 : Column 1089W—continued

Parental Responsibility

Sir John Stanley: To ask the Parliamentary Secretary, Department for Constitutional Affairs whether he will implement the 1996 Hague Convention on Jurisdiction Applicable Law Recognition Enforcement and Co-operation in respect of Parental Responsibility and
 
13 Jul 2004 : Column 1090W
 
Measures for the Protection of Children in the same time scale as the EU Parental Responsibility Regulation comes into effect; and if he will make a statement. [183669]

Mr. Leslie: The new EU Parental Responsibility Regulation will come into force on 1 March 2005. Implementation of the Hague Convention requires ratification on an EU-wide basis. This will require enabling legislation in a number of member states. The Government are committed to bringing forward enabling legislation for the UK as soon as parliamentary time allows.
 
13 Jul 2004 : Column 1091W
 

HEALTH

Alcohol (National Harm Reduction Strategy)

Ross Cranston: To ask the Secretary of State for Health what progress has been made in carrying out the national audit of alcohol treatment services recommended in the National Alcohol Harm Reduction Strategy for England; and if he will make a statement. [182788]

Miss Melanie Johnson: The treatment audit is on course for completion by quarter 1 of 2005 as planned.

Ross Cranston: To ask the Secretary of State for Health what progress has been made in setting up the Alcohol Communication Group recommended in the National Alcohol Harm Reduction Strategy for England; and if he will make a statement. [182789]

Miss Melanie Johnson: The first meeting of the cross-Government communications group has been arranged for July 2004.

Allergy Services

Mr. Best: To ask the Secretary of State for Health what the ratio of allergy doctors per head of population is in England. [183330]

Mr. Hutton: The standard ratio used by the Department is per 100,000 population.

The information requested is shown in the table.
Hospital, Public Health Medicine and Community Health Services (HCHS) staff with a specialty in allergy—England, as at 30 September 2003

AllergyNumber (headcount)
Number24
Doctors per 100,000 of the population(21)0.48


(21) Population data is as at 2002 as present data is not yet available.
Source:
Department of Health medical and dental workforce census.



The number of general practitioners with special interests in allergies is not collected centrally.

Ambulance Response Times (London)

Mr. Rosindell: To ask the Secretary of State for Health (1) what the latest average response time is of ambulances to 999 calls in London boroughs; [182833]

(2) what the latest average response time is of ambulances to 999 calls in the London borough of Havering. [182835]

Mr. Hutton: Statistics on average response times of ambulances to 999 calls are not collected by borough or primary care trust.

However, London Ambulance Service response times to all categories of call for the reporting year 2003–04, the latest data available, can be found on the Department's website at: www.publications.doh.gov.uk/public/sb0411.htm
 
13 Jul 2004 : Column 1092W
 

Birth Defects

John McDonnell: To ask the Secretary of State for Health what research he has (a) commissioned and (b) evaluated into rates of birth defects in communities located near to waste incinerators. [163608]

Miss Melanie Johnson: The Department has not commissioned research into rates of birth defects in communities located near to waste incinerators. Several such studies have been published, with no consistent evidence of any association.

Emissions from modern waste incinerators in the United Kingdom are subject to stringent controls introduced since the periods captured in these studies. It is probable that few, if any, of the incinerators studied would have complied with current requirements.

Breast Milk Substitutes

Paul Flynn: To ask the Secretary of State for Health what conclusions have been drawn following discussions with the Food Standards Agency with regard to ensuring the best possible alignment of UK regulations with the International Code for Marketing of Breast-milk Substitutes. [182177]

Miss Melanie Johnson: Rules on the composition, labelling and promotion of infant formulas and follow on formulas are laid down in European Directive 917321/EEC, which is implemented in the United Kingdom through national regulations. Amendments to the Directive are currently under discussion in Brussels with the relationship between the international code and the Directive being one of the issues under consideration.

Chlamydia

John Cryer: To ask the Secretary of State for Health what criteria were used when selecting primary care trusts for the extension of the chlamydia screening programme. [182780]

Miss Melanie Johnson: The criteria used to select primary care trusts for phase II of the national roll-out of the chlamydia screening programme are published on the Department website at: http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/Chlamydia/fs/en

Angela Watkinson: To ask the Secretary of State for Health (1) what criteria were used in selecting pilot areas for chlamydia testing; [183765]

(2) for what reasons Barking, Havering and Redbridge was not selected as a pilot area for chlamydia testing; [183766]

(3) if he will extend the pilot scheme for chlamydia testing to include Barking, Havering and Redbridge. [183767]

Miss Melanie Johnson: The criteria used to select primary care trusts for phase two of the national roll-out of the chlamydia screening programme are published on the Department's website at http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/Chlamydia/fs/en.
 
13 Jul 2004 : Column 1093W
 

Those primary care trusts (PCTs) which were unsuccessful in their bids to participate in phase two of the chlamydia screening programme, including Barking, Havering and Redbridge, were not selected because the expert selection panel felt that other bids better met the selection criteria.

It is the Department's aim that the chlamydia screening programme will be rolled-out across all PCTs by 2008 and we shall be inviting bids for phase three of the programme later this year.

Commission for Patient and Public Involvement in Health

John Austin: To ask the Secretary of State for Health what plans he has for the (a) abolition and (b) transfer of responsibilities of the Commission for Patient and Public Involvement in Health; and if he will make a statement. [183934]

Ms Rosie Winterton: The Government's recommendations in relation to the future of all Department of Health arm's length bodies will be published shortly.

Contaminated Blood Products

Mr. Cousins: To ask the Secretary of State for Health how many deaths from (a) HIV/AIDS, (b) hepatitis C and (c) co-infection from AIDS and hepatitis C as a result of using NHS-supplied contaminated blood products have so far occurred; and how many victims remain alive. [176222]

Miss Melanie Johnson: Information is not collected on the number of people who acquired infections through contaminated blood products and who have died.

The number of haemophilia patients infected with HIV/AIDS from national health service blood products registered with the Macfarlane Trust and who have died are shown in the table.
Number of deaths(22)
1988(23)88
1989–97661
199822
199919
200024
200113
200212
200311
20042
Total852


(22) The Macfarlane Trust does not collect information on the cause of death.
(23) Prior to 1988.


The Macfarlane Trust currently has 391 registrants, and 40 infected intimates (wives and partners).

Information on the total number of patients who have died from hepatitis C as a result of infection through NHS blood products and the number who remain alive and the figure for the number of patients co-infected with HIV/AIDS and hepatitis C who have died are not collected.
 
13 Jul 2004 : Column 1094W
 


Next Section Index Home Page